1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cys(11)-cys(15)-endothelin-1 (11-21) in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (cys(11)-cys(15)-endothelin-1 (11-21)) | Trials (cys(11)-cys(15)-endothelin-1 (11-21)) | Recent Studies (post-2010) (cys(11)-cys(15)-endothelin-1 (11-21)) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 44 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Koster, BM; Elferink, JG | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cys(11)-cys(15)-endothelin-1 (11-21)
| Article | Year |
|---|---|
Modulation of human neutrophil chemotaxis by the endothelin-B receptor agonist sarafotoxin S6c.
Topics: Calcium; Chemotaxis, Leukocyte; Cytoplasm; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Humans; Interleukin-8; Leukotriene B4; Lymphocyte Activation; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peptide Fragments; Peptides, Cyclic; Platelet Activating Factor; Receptors, Endothelin; Vasoconstrictor Agents; Viper Venoms | 1996 |